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Abstract
Background
Vulnerable individuals with tuberculosis (TB) struggle to access and stay on treatment.
While patient-related and social barriers to TB treatment adherence are well documented,
less is known about how the organisation and delivery of TB care influences adherence
behaviour.
Aim
To examine the influence of TB service organisation and culture on patients’ experience of
starting and staying on treatment in Riga, Latvia.
Methods
An intervention package to support adherence to TB treatment amongst vulnerable patients
in Riga, Latvia was piloted between August 2016 and March 2017. Qualitative observations
(5), interviews with staff (20) and with TB patients (10) were conducted mid-way and at the
end of the intervention to understand perceptions, processes, and experiences of TB care.
Results
The organisation of TB services is strongly influenced by a divide between medical and
social aspects of TB care. Communication and care practices are geared towards address-
ing individual risk factors for non-adherence rather than the structural vulnerabilities that
patients experience in accessing care. Support for vulnerable patients is limited because of
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Conclusion
Providing support for vulnerable patients is challenged in this setting by the strict division
between medical and social aspects of TB care, and the organisational focus on patient-
related rather than systems-related barriers to access and adherence. Potential systems
interventions include the introduction of multi-disciplinary approaches and teams in TB care,
strengthening patient literacy at the point of treatment initiation, as well as stronger linkages
with social care organisations.
1 Introduction
The Baltic republic of Latvia is one of 18 high priority countries for tuberculosis (TB) control
in the World Health Organization (WHO) European Region, and has a high burden of multi-
drug-resistant tuberculosis (MDR-TB) [1,2]. In 2016, 560 new TB cases and 100 retreatment
cases were registered in Latvia, among them 32 and 21 MDR TB cases respectively [3]. The
country has undergone drastic changes in TB notification rates over the past 20 years [2]. After
the collapse of the Soviet Union in the early 1990s, TB rates increased substantially, and only
started to decline after 1999, partly due to rapid economic growth in the Baltic region and the
adoption of a centralised, strictly followed programmatic approach to management of TB. The
TB incidence rate increased again in 2012, coinciding with the global economic crisis that hit
Latvia harder than any other EU Member State. Unemployment rates increased, and a large
part of the population experienced a decline in socio-economic status and health [4]. At the
same time, the number of HIV cases in Latvia rose sharply; by 2012, 20% of those diagnosed
with TB also had HIV.
From 2013 to 2016, the situation improved again, with registered new TB cases declining
from 38.1 per 100 000 in 2013 to 28.4 in 2016 [5]. However, vulnerable and socially marginal-
ized individuals are disproportionately affected [6]. Despite a high treatment success rate
(88%) among new drug-susceptible TB patients, factors influencing unsuccessful treatment
outcomes in vulnerable individuals including unemployment, alcohol and drug use, and HIV
are consistently reported in epidemiological studies on TB and drug-resistant (DR) TB in the
Baltic States [1]. However, there are no known studies that look at the responsiveness of the
health system vis-à-vis vulnerable individuals, for whom a number of these risk factors may be
conflated. Here, we draw on a qualitative study of TB care in Riga, Latvia, to examine how
patients with atypical circumstances that compromise their health and health-seeking navigate
standardised TB care pathways.
Social science literature on infectious disease control programmes suggest that the way in
which the disease, treatment approach, and treatment adherence are conceptualized have
important bearing on how care is delivered. Although there are recent appeals for a patient-
centred focus in tuberculosis care [7], this is a relatively novel paradigm for TB. Unlike HIV
care, which espoused patient-centred approaches to address behavioural risk factors from the
outset, TB management has historically focused more tightly on biomedical determinants of
infection [8]. The predominant perspective, from which directly observed therapy (DOT) and
other clinic-based interventions are designed, views the patient as a passive recipient of profes-
sional medical care [9]. Though previously regarded as a vital element of global TB control
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programmes, DOT has been criticized as paternalistic, and when rigidly implemented, serves
to “reinforce asymmetrical relations of power between different constituencies, and to strengthen
conventional modes of provider-patient interaction” [10]. Advocates of a patient-centred
approach to TB care have been vocal about the need to change terms commonly adopted by
TB programmes, such as terms like ‘compliance’, ‘defaulter’, and ‘control’ which reflect top-
down and disempowering views of patients [11]. However, the change in language from ‘com-
pliance’ to ‘adherence’ which ostensibly grants greater agency and choice to patients may in
fact place undue responsibility for treatment completion on the patient [12] and detract from
the structural factors affecting an individual’s ability or will to complete treatment [13]. An
emphasis on structural vulnerabilities recognises that some patients struggling to stay on treat-
ment live within risk environments [14] where a range of social determinants of ill health
including gender, poverty, and social marginalisation diminish their capacity for agency in
health-seeking behaviour, including following a treatment regimen [15–17].
Patient-centred approaches that take account of underlying social and structural factors
influencing patients’ abilities to begin and stay on treatment [18–20] may extend beyond the
clinic to include families, peers, and social networks [21] but must also include critical reflec-
tion on the ways in which health systems themselves may perpetuate a paternalistic and disem-
powering view of patients. In this paper, we argue that it is important to understand the clinic
as a site of social and professional norms and relationships, in line with recent calls for actor-
oriented and relational research on health systems [22]. Examining the organisational context
and social relations of TB care can shed light on health provider assumptions of what consti-
tutes ‘good care’ and how it should be delivered. In turn, these insights reveal opportunities to
enhance patients’ experience of TB care within the health system, from coming to terms with a
diagnosis, to navigating complex pathways to care, and staying motivated while on treatment.
2 Methods
2.1 Context of study
This paper reports qualitative findings drawn from a mixed-methods process evaluation of a
pilot intervention study that took place between January 2016 and March 2017 in Riga, Latvia
under the auspices of the Centre for Tuberculosis and Lung Diseases (CTLD). The CTLD is
one of six clinical centres of the Riga East Clinical University Hospital (Riga, Latvia), with TB
diagnostic and treatment services free of charge and financed by the state. Patients are usually
diagnosed and initiate treatment in hospital and continue on ambulatory basis once they are
smear negative, able to tolerate treatment well and when it is possible to ensure ambulatory
directly observed therapy (DOT). Culture positive samples from each patient undergo drug
susceptibility testing. All patients are offered HIV testing; those found to be HIV infected are
offered co-trimoxazole preventive therapy (CPT) and antiretroviral therapy (ART) [1]. In
recent years, the TB treatment success rates in Riga and the Riga region have been high overall
(80.5% in 2014) but remain below the target rate of> 85%. The current model does not work
for some patients, as indicated through the loss-to-follow-up rates of approximately nine per-
cent of all patients (personal communication, TB doctor, CTLD), indicating that there are
some persistent challenges with adherence to TB treatment.
We piloted an intervention designed to improve adherence of patients to TB treatment.
There were three components to the intervention. Firstly, a two-day training workshop was
held to strengthen patient communication skills among all staff involved with TB patient care.
Secondly, a psychosocial risk screening tool to identify those TB patients likely to struggle with
adherence to treatment was developed, based on an existing adherence risk screening tool
developed for TB services in London in 2012. It was adapted to the Latvian context and
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streamlined to facilitate incorporation into routine clinical practice. Thirdly, patients identified
by the screening tool as having one or more risk factors for non-adherence were provided with
an additional adherence support meeting with the head ambulatory nurse. These patients were
closely followed up and offered help with finding suitable housing, referral to a psychologist
and financial support to cover travel costs, where needed. The objectives of the pilot interven-
tion study were: 1) to compare adherence and culture conversion times in patient cohorts
before and after implementation of the intervention; and 2) to conduct a process evaluation of
implementation of the intervention, considering patient and staff perceptions and experiences
of delivery of care during the intervention period. In this paper, we draw on the qualitative
data collected in the process evaluation to highlight the importance of social organisation and
culture of TB service delivery in the trajectories of vulnerable patients on treatment.
2.2 Sampling and recruitment procedures
The European Centres for Disease Control (ECDC) issued invitations to a wide range of Euro-
pean institutions providing specialised TB care to act as host sites for implementation research
to contribute to the goal of “increased TB treatment adherence and improved treatment out-
comes among specific hard-to-reach and vulnerable population groups in the EU/EEA”. The
chief of medicine at the CTLD expressed interest to host a project and sent an official agree-
ment letter to ECDC, granting permission and arranging the logistics of data collection for the
researchers from LSHTM and QMU during two separate periods of fieldwork at CTLD and its
affiliated partner and satellite sites. Participants for the qualitative interviews were purposively
selected based on their involvement in either providing or receiving TB care. Fourteen health
providers involved in TB care and support were interviewed. They were either based at CTLD
or were from relevant referring departments and affiliated institutions including: the ‘satellite’
DOT clinic in the city centre, the MDR-TB ward of CTLD’s inpatient department, a shelter
that refers individuals to CTLD for TB testing, and a non-governmental organisation (NGO)
providing support and counselling services for individuals affected or co-infected with HIV.
At the time that patient interviews were held (four months into the intervention), 30
patients had initiated TB treatment. On screening, about half of these patients exhibited one or
more risk factors for poor adherence to treatment. The TB nurse at CTLD approached each of
these patients regarding their willingness to participate in the study, and ten patients expressed
interest. After explaining the project to the patients, written consent was obtained for the
researchers to conduct and record the interview using a digital voice recorder.
2.3 Data collection
Data collection took place over the course of four site visits between January 2016 and March
2017 and included observations, semi-structured interviews, and review of patient records and
notes. NV and KK conducted semi-structured interviews and observations with staff and
patients midway and at the end of the intervention period, with the help of two Latvian
research assistants (RAs) who provided ongoing translation. During the first round of data col-
lection, all 14 health providers and 10 patients were interviewed. Follow-up interviews were
conducted with six of the 14 health providers during the second round of data collection. To
preserve anonymity in reporting, all patients and staff members interviewed were assigned cul-
turally appropriate pseudonyms.
Patient interviews (Table 1) were conducted in Latvian, Russian or English and elicited
information about patients’ backgrounds, their family situation, and their health, including
being diagnosed with TB. We then focused on their experiences with treatment initiation, care
and support, communication with providers at each stage of treatment, as well as the broader
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familial and social context of their medicine-taking behaviour. We gained further information
on these patients’ trajectories within the health system from notes on patients’ records that
were reviewed with the assistance of the CTLD head nurse to supplement the development of
patient case studies. These patient records were a subset of a larger sample of records included
in a retrospective record review that was conducted to collect quantitative data on treatment
adherence and on bacteriological conversion times (not reported here).
Staff interviews (Table 2), conducted in Latvian and English, initially elicited information
about staff members’ background, length of time working at CTLD, their roles, and their par-
ticular responsibilities in TB care. We then moved to asking about the organisation and pro-
cesses of TB care, and obstacles and facilitators to delivery of the intervention within this
setup. Staff members were encouraged to focus on concrete examples of patients (without
Table 2. Staff interview participants.
Pseudonym Staff member role Follow up interview conducted?
1. Marta Sputum collection nurse, CTLD
2. Dr L Head of CTLD ambulatory department
3. Dr A TB physician 1, CTLD ambulatory department x
4. Dr B TB physician 2, CTLD ambulatory department x
5. Guna TB nurse, CTLD ambulatory department x
6. Dr C TB physician 3, MDR-TB ward) x
7. Jana Head TB nurse, MDR-TB ward
8. Marija TB nurse, MDR-TB ward
9. Alise Psychologist/social worker, HIV NGO
10. Sofija Social worker, homeless shelter
11. Anna Courier, CTLD ambulatory department x
12. Anita Head TB nurse, CTLD ambulatory department x
13. Ilze Social worker, CTLD
14.Kristine TB DOT nurse, satellite clinic
Not referred to in manuscript.
https://doi.org/10.1371/journal.pone.0203937.t002
Table 1. Patient interview participants.
Pseudonym Characteristics
1. Jevgenijs Male, early 50s, originally from Ukraine, unstable housing status, history of alcohol and substance use
2. Sergejs Male, approx. 60s, from Riga, receives disability support, has heart-related health problems, lives
alone
3. Viktors Male, mid 30s, Russian speaker, bartender, history of substance use
4. Andris Male, early 50s, part-time mechanic, mobile home, separated from spouse and children.
5. Igors Male, mid 30s, unemployed, from Riga, wife and child in treatment for TB, history of alcohol use
6. Amadi Male, early 30s, refugee from Eritrea, was living in refugee camp
7. Dainis Male, late 40s unemployed, from Riga, second time being treated for TB, history of alcohol use
8. Ludmila Female, approx. mid-40s, unemployed, from Riga but declared in another city, history of alcohol use
and victim of domestic violence
9. Kaspars Male, approx. 40s, unstable employment, has lived in Riga for 20 years but originally from another
region in Latvia
10.
Natalija
Female, approx. mid-30s, Russian speaker from Riga, lives with husband and child
Not referred to in manuscript.
https://doi.org/10.1371/journal.pone.0203937.t001
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naming them) in order to illustrate their perspectives on the challenges of adherence to TB
treatment for this population. Structured observations were conducted midway and at the end
of the study period at different points along the patient pathway including: the CTLD DOT
room, the TB physician’s office, the CTLD registration desk and the satellite DOT clinic in
Riga’s city centre.
2.4 Data management, processing and analysis procedures
As interviews were conducted with the help of an RA, transcripts of recordings were not verba-
tim, but of the English translation of responses. The RA listened to each recording, checking
over and editing the transcripts where needed. NV and KK reviewed all transcripts (interviews,
observations and field notes) several times before entering them into NVivo qualitative data
analysis software, version 10. A process of open coding around the broad topic of ‘organisation
of TB care for vulnerable patients’ led to a framework focusing on four different dimensions of
care: infrastructural context; professional roles and relationships; procedures and processes;
and patient-provider interaction and communication. In further analysis, we examined how
these dimensions played out at different stages of standardised processes including risk screen-
ing, diagnosis and treatment initiation, DOT and adherence support.
2.5 Ethical considerations
Ethical approval was obtained by the ethical review boards at Queen Margaret University
Edinburgh (UK), The London School of Hygiene and Tropical Medicine (UK) and the Riga
Stradins University, Latvia. All identifying information relating to staff and patients was anon-
ymised. In the paper, we used pseudonyms rather than numbers to humanize patients’ and
staff narrative accounts and quotes. For some staff interviewees, we used initials that have no
connection with actual names. All participants were provided with information sheets detail-
ing the objectives of the study and their rights as participants. The researchers reviewed the
information sheet with the participants prior to the start of each interview and written
informed consent was obtained from each study participant.
3 Results
In this section, we present results from the qualitative components of the process evaluation
under four sections that correspond to significant points along patients’ trajectories in TB
care: risk screening, diagnosis and treatment initiation, adherence support, and DOT. In docu-
menting these four phases of patient pathways through the clinic, we focus on organisational
context and culture of TB care as important systems features that influence patients’ experi-
ence of starting and staying on treatment.
3.1 ‘It’s very difficult to define this vulnerability’: from risk factors to
structural vulnerabilities
A central feature of epidemiology is the investigation of individual and population-level risk
factors as primary causes of disease or behaviours deemed to be detrimental to health. The risk
factor approach has been criticised as overly individualistic and reductionist as it masks the
underlying reasons that place particular individuals at risk [23]. Despite considerable debate
around its limitations, the emphasis on ‘risk factors’ continues to dominate mainstream epide-
miological research. In clinical practice, this approach is reflected in screening tools that assist
triage and decision-making around eligibility for further diagnostic procedures, treatment reg-
imens or other forms of care and support.
Social organisation of tuberculosis care in Riga, Latvia
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For staff at CTLD, screening of patients at the time of treatment initiation is used to assist
in early identification of risk factors for poor adherence to treatment. By early March 2017, 67
patients had been enrolled at CTLD, and just over half of them (52.2%) were noted to have one
or more risk factors for poor adherence to TB treatment, the most commonly noted being:
excessive alcohol consumption (n = 14); living outside of Riga city or not being a registered
resident of Riga (n = 12), and social isolation (n = 14), defined as limited or no recourse to
family or friends who could support them whilst on treatment.
Through a checklist, the screening tool enables the TB nurse to take note of specific issues
that hinder a patient’s capacity to follow a treatment regimen. However, the standardised
nature of the tool isolates specific risk factors as generic patient-related characteristics, mask-
ing the complex dynamics of underlying vulnerability that puts some patients not only at risk
for ‘poor adherence’ to TB treatment, but more broadly, at risk for compromised physical and
mental health.
Being ‘at risk’ for poor adherence to treatment starts long before the diagnosis of TB and
has more to do with situational circumstances than with individual characteristics. For a num-
ber of patients interviewed, the entry point to TB care was not directly related to TB symptoms
but to other illnesses or conditions that compounded the burden of physical disability and dis-
tress and complicated access to care. Ludmila had been on treatment for two months when we
spoke to her and was noted to have two main risk factors for poor adherence: a history of alco-
hol abuse and social isolation. However, of equal importance to her ‘risk’ profile is the fact that
Ludmila is diabetic. When she sought care for a cough and raised temperature that would not
disappear, she was told that her diabetes had weakened her immune system. Upon being
informed that she had TB following an x-ray, she expressed shock and uncertainty about how
to manage the dual burden of disease. Similarly, Jevgenijs, who was initially admitted with an
injury incurred while drunk, has also had problems with alcohol and narcotics use in the past
which puts him ‘at risk’ of poor adherence. The diagnosis of TB places an additional burden
on his pre-existing HIV status which he lamented as “creating many problems in my life”. Ill-
ness histories of patients deemed ‘at risk’ of poor adherence were often closely intertwined
with precarious working conditions. Like Jevgenijs, Andris and Dainis were diagnosed with
TB through a circuitous route. Both suffered accidents while working, which led them to seek
acute care. Andris, a part-time mechanic in his early 50s, broke a bone in his upper shoulder.
Dainis, a stair cleaner in his late 40s, suffered a bad fall a number of years ago and broke his
ribs which led to him not being able to work.
Jevgenijs and Andris were also deemed at risk for poor adherence to treatment because
they had no fixed abode in Riga. Andris is originally from a town about one hour away. Sepa-
rated from his wife, he lives in a camper van. In his profile, as in that of others we interviewed,
the significance of being ‘without fixed abode’ extended far beyond a bureaucratic hurdle in
accessing municipal services to encompass the consequences of mobility, fragmented social
ties, marginalisation, and interrupted patterns of care-seeking. When Andris had his accident,
he first went to a doctor in Riga, but was advised to seek help from a doctor in his hometown.
The doctor in his hometown suggested he go for another x-ray in Riga, which revealed “some-
thing wrong with my lungs”. He was admitted to the hospital and discharged after a week but
remained unsure about whether he had TB or not. Kaspars, originally from a town approxi-
mately 200 km away, has been in Riga for twenty years, yet experiences acute job insecurity.
Since being forced to give up his small business during the 2008 financial crisis, he has been
‘unofficially’ employed in construction work. Anxious about missing sporadic work opportu-
nities, he told us that he generally avoided doctors and self-medicated in the case of feeling
unwell. In his case, he delayed seeking care for the fever and unusual pain in his side that he
was experiencing, only calling emergency services when the pain became severe.
Social organisation of tuberculosis care in Riga, Latvia
PLOS ONE | https://doi.org/10.1371/journal.pone.0203937 October 17, 2018 7 / 18
The impact of having ‘no fixed abode’ is especially poignant for migrants. Amadi, a refugee
in his 30s from Eritrea, came to Latvia in July 2016 via a long and difficult route with ‘transit’
time spent in a number of countries as an asylum seeker. He was tested for, and diagnosed
with, TB as part of the requirements of his refugee status. In addition to TB, he was also found
to have nutritional deficiencies and pleurisy. He was hospitalised for a few weeks, then dis-
charged, but returned to see the doctor again after feeling unwell, and went back to the hospi-
tal, this time for two months. At the time of interview, he was living in a refugee camp outside
of Riga Municipality and was not working. He speaks English but does not speak Latvian or
Russian; in his interview with us, he became increasingly despondent and pessimistic about his
ability to negotiate not only the health services, but more broadly the ‘system’ per se.
Among the CTLD staff, there was consensus that the discreet ‘risk factors’ identified
through the screening checklist predisposed individuals to non-adherence, but also shared
agreement that the ‘social part’ was as relevant to the progress of patients on TB treatment as
their clinical profile. Some staff recognised, that ‘risk factors’ were intertwined and that indi-
viduals ‘at risk’ of poor adherence were embedded in social contexts that were characterised by
their vulnerable structural position. Dr C, who works in the MDR-TB ward, provided an
example of the challenge in assessing who was really ‘at risk’ of poor adherence:
It’s very difficult to define this vulnerability. For example, for some women we know that they
probably have some money and [health] insurance and so on . . . but we don’t know what hap-
pens in their family. Maybe there is some violence in the family and this is the factor that
impacts later on the adherence.
In eliciting information about patients’ backgrounds, we found that a risk factor approach
was inadequate, barely skimming the surface of the profound social challenges that many
patients in this setting faced. For Ludmila and other patients introduced above, the circum-
stances leading up to a diagnosis of TB illustrate that individual ‘risk factors’ are often inter-
twined in a web of structural vulnerabilities. Individuals who experience compromised health,
homelessness, and social and economic marginality have limited power and social capital to
negotiate the health system, not only at the point of accessing a diagnosis, but throughout the
treatment pathway, as we observe in the following sections.
3.2 ‘In the hospital, it was like a factory’: coming to terms with a diagnosis
Diagnosis is a critical transitional moment in the care-seeking trajectory of individuals.
Through a diagnosis, signs are converted into symptoms, the individual becomes a patient,
and the therapeutic course of action is legitimised through recourse to institutional knowledge
and authority. In practice, however, diagnostic uncertainties abound, in particular for more
complex and chronic diseases, which can involve navigating different levels and components
of a health system. In this study, the system for managing ‘difficult’ cases of TB is well-laid out
and effectively coordinated from the providers’ point of view, however patients who partici-
pated in the study all experienced some uncertainty and confusion during their diagnostic
journey.
All patients with a confirmed TB diagnosis receive TB treatment in hospital for a minimum
of 2 weeks while they are smear-positive, or longer, depending on their tolerance to medica-
tions, and social factors, including financial, housing, and general support circumstances. If
found to have DR-TB, they are kept in an isolation ward until smear conversion. For a number
of patients, the experience of initiating treatment during hospitalisation was stressful. Dainis,
who initially sought care for broken ribs, described his initial transfer to the hospital as a “big
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mess”. He moved from the 4th floor, where patients are admitted after the initial diagnosis, to
the 7th floor when they realised he had DR-TB. He was found to be resistant to one drug and
then moved to the 6th floor, familiar to him from his past admission for TB, 20 years ago. In
contrast to the first time he had TB, there was no long conversation at this point; he was simply
given documents to sign. Jevgenijs’ experience of diagnosis was also distressing. He was first
referred to the infectious diseases department by his HIV doctor because of a high temperature
and kept there for a week before being checked for TB. He was then sent to the TB hospital
and admitted to the isolation ward where he was diagnosed with MDR-TB. He tried to escape
but broke his hip and was re-admitted and placed in isolation.
During hospitalisation, the doctor who sees the patient first confirms the diagnosis, tells
patients about the treatment regimen, potential side effects of medication as well as co-mor-
bidities. This technical information is difficult to absorb at a time when patients are in a state
of shock about their diagnosis. Anita, the head TB nurse at CTLD, noted that patients were
often “. . .a little bit afraid of the doctor [. . .] it’s something [about the] authority as a doc-
tor. . .because the doctor is so busy and [they] can’t ask them anything”. Marija, a nurse on the
MDR-TB ward of the main hospital was frequently asked to confirm what the doctor had said,
or to provide further information, because patients had not digested the information the first
time it was given to them. There was, she said, little room for patient education at this stage, as
her main duty was to ensure distribution of the drugs and necessary injections.
Kaspars, who delayed seeking care, expressed anger with the delays in establishing a diagno-
sis: he underwent a number of tests and investigations in the infectious diseases ward before
being moved to the TB hospital for further tests, where the doctor told him that the diagnosis
was a big “mystery”. The uncertainty around the diagnosis was distressing—“I didn’t sleep for 3
days”–and when finally confirmed, disclosure occurred in an abrupt manner, with a doctor
informing him in the presence of other patients. He felt that his rights to confidentiality had
been breached and described the TB hospital as a “factory” where “nobody takes care, nobody
pays attention. Nobody. One patient, then the next, the next. . .”
The hospital environment can be alienating not only in terms of the lack of communication,
but also because it represents a space where normal social relations are suspended. For patients
like Kaspars and Viktors, a bartender in his mid-30s, the hospital stay was sobering as they
found themselves in the company of people they perceived as socially inferior to them. Kaspars
noted the number of homeless people in the hospital, commenting that this might be the rea-
son the doctors there did not seem to connect with their patients. Viktors, although frank
about his own history of alcohol addiction and drug use, bitterly described his shock at being
amongst “. . .bums and addicts”. He felt let down by a system that put him back into a context
and an identity he was trying to escape:
I haven’t drunk alcohol in 4 years, haven’t been out in a year. My one bad habit is smoking. I
try to keep away from these people as much as possible. Now I am amongst them. I spent one
week re-evaluating my whole life.
Ludmila, who spent a month in the hospital, was more forgiving of her time as an inpatient:
“I have nothing bad to say about the doctors and the workers. They treated me so well. They have
such a low salary and work in such a place, we can only thank them”.
The time spent in the hospital represents an important starting point for patients as they
come to terms with diagnosis. However, although she expresses gratitude for the care she
received, Ludmila’s words reflect the extent to which the hospital is perceived as a de-humanis-
ing environment for patients and staff alike, and a missed opportunity for strengthening treat-
ment literacy. During this critical phase when patients are initiated on to treatment, negative
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experiences are likely to have bearing on individuals’ self-identification as TB patients, their
awareness of the course of illness and their readiness to embark on a long-term, challenging
treatment regimen.
3.3 ‘Treatment is of primary importance, and social assistance is secondary’:
Dividing the labour of TB care
Following their discharge from the hospital, patients are registered for ambulatory treatment.
The ambulatory phase of treatment is strictly monitored, and within a context of program-
matic vigilance, staff become more acutely aware of the factors that are likely to affect patients’
adherence patterns. From this point on, professional boundaries resulting in divisions in the
organisation of TB care become more apparent, with implications for the allocation of
resources and delivery of services that support patients on treatment.
During the initial consultation, the ambulatory clinic doctor takes a clinical history and
establishes the treatment plan, while a TB nurse elicits patients’ address, contacts and phone
numbers, as well as basic risk factors. Patients coming from the hospital are asked to sign a
consent form to declare that they have understood the information provided regarding the
duration of the treatment, what kind of complications are possible, and what happens if the
patient stops taking the drugs. As in the hospital, the focus is on clinical management and the
verbal exchange between the health staff and the patient is restricted to establishing risk factors
and securing patient compliance to the treatment regimen. Dr A, one of the ambulatory doc-
tors, affirmed the division of labour between herself and the nurse:
I personally do not go very deep into the social problems because after the interview I ask
[Anita, head TB nurse] how she feels about this person. For me as a doctor, I explain what the
patient is to receive, for how long. . . the medical information. Then for me it’s interesting
when [Anita] reports back to me because I don’t [have to] ask this. . .I appreciate this.”
Following the consultation with the physician in the ambulatory clinic, all patients enrolled
during the project period have an additional meeting with Anita. In this meeting, she elicits
more information about the patients’ social circumstances, and spends time gauging their
understanding of the condition and the course of treatment.
Overall, the experience of the initial consultations with the doctor and nurse were experienced
by patients as positive and helpful, often contrasted with the confusion and distress experienced at
time of diagnosis. Anita recalled her first meeting with Kaspars as terse—he appeared to have
some “mental problems” and nervous mannerisms—but noted he had progressively gained trust
and was able to take his treatment regularly. He contrasted his ambulatory care favourably with
the negative experience of the hospital: “everything here [at CTLD] is humane. . . it’s civilised”. Dai-
nis, too, praised the nurses, saying that they always showed interest in how he felt.
During her meeting with patients after their transfer to the ambulatory clinic, Anita fills out
the psychosocial risk screening form to establish if the patient might require additional social
support. Social support is categorised broadly into financial assistance, psychological support,
or referral to a narcologist, a Soviet-era specialist psychiatrist trained in the study and treatment
of alcohol and drug abuse. While many patients are entitled to financial assistance in the form
of transport money and food vouchers from the Municipality of Riga, patients can only receive
social support if they are declared residents, with a documented address within Riga City. This
presents a challenge for homeless patients or those who are registered in different cities yet live
in Riga. Dainis, for example, did not have access to a general doctor because he was not
declared in Riga City, and only obtained the declaration when he spent some time in a shelter.
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Applying for social assistance can be cumbersome. Ilze, a social worker based part-time at
the ambulatory clinic, establishes whether a patient is entitled to financial assistance, and helps
eligible patients fill out the application. She reviews the patient database to verify patients’
social and residency status, however sees few—if any—patients in person on a daily basis,
instead relying on phone calls to make contact. This is challenging, she avowed, as patients
were often resistant to being called and reluctant to provide information about their where-
abouts or social contacts. Ultimately, the assistance provided may only make a small difference
for the financially least well-off patients, and often falls short of patients’ needs. Kristine, one
of the DOT nurses was vocal in her critique:
It’s too little money that the social assistance gives for food, there is this system of coupons and
every 10 days, patients get 4 coupons and each coupon is worth 1 Euro 60. This is meant for
food but it is not sufficient . . . It’s about 19 Euro 20 per month [but the patients] need more
protein, like cottage cheese. It’s not enough!
Addressing mental health issues among patients identified as being at risk of poor adher-
ence was often restricted to finding out if there was a family member close to the patient. Yet
when we asked to what extent family members accompanied patients or acted as treatment
supporters, Anita, the head TB nurse, contrasted spousal and familial relations in Latvia with
those in other countries: “In Latvia, we don’t have these kind of strong relations. . .we don’t see
family members who help in the treatment period”.
Referring someone for psychological support services was not readily accepted by patients,
first because of the sensitivity of the issues and patients’ reluctance to present with ‘mental’
issues [24], and second, because of the associated costs: a visit to the psychologist or a therapist
was expensive and therefore potentially out of reach for vulnerable patients. There is no resi-
dent psychologist in the TB ambulatory clinic, but TB patients are sometimes referred to a
counsellor from an HIV non-governmental organisation (NGO) in the city.
Unlike HIV, there was less ‘enthusiasm’ for TB, Dr A commented, and no TB NGOs she
was familiar with that might provide similar psychological help. She was aware of two mentally
distressed patients who had been advised to see the psychologist at the HIV NGO, however
was unsure whether they had made use of this service, as there was no follow-up. Andris and
Ludmila were both offered the opportunity to consult with a psychologist based on their risk
profile but declined as they didn’t feel it was necessary. Some staff suggested that patients
might not be comfortable with talking to health workers. Anita reflected that “. . .patients don’t
like to come here and spend extra time or ask for more information. It’s only if I see them in the
corridor”. She added: “In Latvia, our mentality is that we are not so open. . .”
When asked whether Ilze, the social worker, could provide some psychological support for
patients, staff seemed surprised by the question, arguing that social workers did not have the
training or skills to do so. Ilze herself said she would rather leave this to a doctor, as “patients
trust the doctor more”. She reminded us: “In this clinic, treatment is of primary importance, and
social assistance is secondary. . . it is more auxiliary work”. Dr C suggested that the low status of
social workers in clinical settings was not a human resource issue, but rather that “. . .there is
no full understanding about this work” on the part of the authorities. She noted:
If we demand more social workers, the response would be that there are enough. There is
one staff member for beds and that is enough. I think the problem is that the understanding
of social work is very narrow. We see only the pension, the document work, passport,
immigration registration and so on and that’s it. But to go a little further to understand
what we have to do, I think this is the problem of awareness.
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All staff members noted numerous challenges with vulnerable patients who had alcohol or
substance use issues currently, or in the past. While there was an understanding of the social
determinants of excessive alcohol use, drunkenness was frequently described as making the
work of staff difficult, leading to ‘bad behaviour’, ‘rudeness’ and malingering, or ‘lying’ about
not being able to come in for DOT. Dainis was made aware that mixing alcohol with the drugs
was dangerous as the “drugs are like poison”; at times, he struggled to find a balance between
his drinking habit and medication, expressing concern about having to go back into isolation
if his treatment was compromised. Anita worried, too, about Viktors’ past ‘heavy drinking’
habits and the possibility of his relapse: “. . .if there are some pressures from diseases or family or
friends or something else, they can go back”.
For patients with substance abuse issues, assistance is similarly limited by the lack of inte-
gration of health and social services, and the perception that the latter do not fall within the
remit of TB care. Individuals are informed about where they can get help, if they want it. This
assistance compartmentalises addiction issues as separate disease conditions requiring differ-
ent types of expertise. There is only one narcologist who works with the municipality social ser-
vices; referrals to addiction specialists otherwise require payment. Dr B, one of the TB doctors
in the ambulatory clinic, expressed her professional limitations in dealing with the care and
follow-up of drug users on treatment, suggesting the clinic would benefit from hiring a part-
time narcologist, if finances permitted. The limitations in skills, resources, and capacity to
address ‘social problems’ as articulated by the staff have repercussions for patients’ whose
capacity to adhere to treatment is compromised by structural vulnerabilities. As seen in the fol-
lowing section, non-adherence to DOT is not a clear-cut pattern of missed doses; rather, it sig-
nifies lapses in the ability to take care of one’s health triggered in most cases by critical events
in patients’ lives.
3.4 ‘It’s actually work to come here and take this medication’: Starting and
stopping DOT
Following assessment of their clinical and psychosocial profile, patients are started on daily
DOT either in person or via a Skype call. DOT is offered at both CTLD as well as a satellite
clinic in the city centre. The DOT nurse is potentially a pivotal figure in terms of maintaining
contact with patients on treatment. At both DOT sites, the nurses are responsible for monitor-
ing treatment intake and relaying information about patients who have missed their daily
doses. At the outset of treatment, communication with patients is vital to reinforce the neces-
sity of adhering to the daily schedule of treatment. As Guna, one of the DOT nurses, pointed
out: “It’s important to remind them that they need willpower. . . that it’s actually work to come
here and take this medication”. However, following the initial ‘induction’ to treatment, patient
contact with staff becomes more sporadic and sparse over time. Both Jevgenijs and Sergejs,
another study participant, said they were not familiar with the staff and did not know their sur-
names, and generally avoided contact with other patients. Andris was generally satisfied with
the care received but commented that the attitude of the nurse providing DOT was “like being
in the army. . .in her room, you must go by her rules”.
Viktors resented having to come to the clinic every day: “It’s a big demand on my time. I
understand that taking tablets is in my interest, but I don’t see why I have to come here all the
time.” Although he praised the head TB nurse Anita’s competence and ‘loyalty’, he was more
critical of other staff, who he said were too caught up with their professional guidelines–”they
only say what they are supposed to”–rather than being flexible of patient circumstances. His
main concern with DOT, despite the clinic’s flexible opening hours, was that he felt it con-
strained his capacity to work, and therefore to pay off his debts. He was desperate to finish
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treatment: “I want them to let me out as quickly as possible . . . so they don’t extend my sick
leave”. The CTLD has a courier, Anna, whose role is to follow up on patients who have not
shown up for their daily DOT through home visits. She receives a stack of records of people
who are ‘missing’ from the nurse, which she tries to process one-by-one. Her intervention is
critical for vulnerable patients struggling to stay on treatment, however home visits can be
time consuming, tiring, and sometimes frustratingly ineffective.
There are challenges locating addresses and getting into buildings, and occasionally, secu-
rity risks. One patient who used to come regularly had stopped coming about a month ago; in
way of explanation, Anna, the courier, told us that this date coincided with the anniversary of
his wife’s death which he had ‘commemorated’ meaning he had resumed drinking alcohol.
Although he had been placed in social housing away from the centre of town, he had returned
to an earlier abode, which Anna vividly described as an old and dilapidated building with “bro-
ken windows and a narrow and dark staircase”, a place she was afraid to visit. Overall, Anna
was modest about what she could do, emphasising that she contributed to the team, but was
limited due to her lack of “education in medicine and professional knowledge of TB”, reinforcing
once again the widely held stance that care for TB patients was foremost the domain of
clinicians.
Two cases of patients who were lost to follow up illustrate the difficulties of retaining all
patients in care. Ludmila, initially positive about her experience at CTLD and optimistic about
staying on treatment, became more irregular in her visits about 3 months after starting treat-
ment. After a fight with her husband, she started drinking again and moved to another city.
Anita noted attempts to contact her through her son after she was ‘lost’ to the system, to con-
firm her health status but he said he no longer had contact with her: it was “too difficult to help
her”.
When we met him, Amadi had been on TB treatment for nearly three months. He took his
tablets regularly, although Anita noted he had nutritional deficiencies and digestive problems
linked to the medication side effects. He met with her a number of times, mainly to ask for
support on immigration issues. Our question about how he was doing on treatment, however,
elicited a chain of causal factors that compromised his health and well-being:
If you need to take a tablet, you need to eat food, but there isn’t any food [. . .] I need to talk to
the doctor because [taking] the tablets is difficult without food [. . .] But it is difficult for us, we
have no money. The government does not care about us. And I have no family, nobody to
come and help. So I applied already [to go to] England because this organisation, they gave me
the documents to go out. They left it with the camp, but I cannot earn. Because I have only
1,139 Euro but if I need to work, how? Maybe it is about 200, 300, it is not enough. It’s a diffi-
cult life for me with my health.
Shortly after the interview, Amadi’s appearance became more erratic, and finally, he
stopped coming to the clinic. Upon inquiry, the CTLD staff was informed by one of the nurses
at the refugee camp that he had left the country before Christmas; he was then classified as lost
to follow up.
The reconstruction of Ludmila and Amadi’s treatment itineraries indicate how social and
structural vulnerabilities affecting some patients’ ability to stay on treatment can culminate in
patients’ disengagement from the health system. In part, the difficulties of responding to these
vulnerabilities are due to a broader context of health care financing challenges in Latvia. As Dr
C pointed out, the overall decline in TB rates has resulted in budget cuts negatively affecting
support for TB patients. Anita commented that she has had a vacancy for a TB nurse open for
two years: working in TB is not appealing, and small salaries do little to dispel the stigma. Two
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of the nurses currently working at CTLD are over 70 years old and highly valued for their loy-
alty and commitment to TB work. Basic health workforce gaps may limit the possibility of
patient follow-up and retention. However, it is the prioritisation of medical over social aspects
of TB care and the resulting divisions in practice and responsibility that precludes the inte-
grated, patient-centred approach that might enable patients like Ludmila and Amadi to stay in
care.
4 Discussion and conclusion
If we can solve the social network problems, we can solve the medical issues. In some cases, it’s
a systematic problem, it’s the restriction of only having 20 minutes, it’s a limitation of the sys-
tem. (Anita, Head Ambulatory Nurse, CTLD)
In the setting observed, the strictly followed programmatic approach to management of TB,
backed by good surveillance, diagnostic and information systems, minimal delays in treatment
initiation, and available medication enables effective and timely organisation and delivery of
care for the majority of patients. This is reflected in the high rates of DOT adherence in the
clinic. Over the course of the pilot study, 90% of 67 patients completed treatment or were
cured, 5% were lost to follow up, and just 4% of the total doses administered were missed.
However, within the clinic, we observed that the emphasis on clinical management and moni-
toring of patients frames TB care in a way that discourages the systems responsiveness to vul-
nerable patients on treatment. The data from Riga provides insights on the challenges of
‘localising’ ideals of patient-centred care in a context where social and structural vulnerabilities
compromising patients’ treatment pathways are seen as beyond the realm of the clinic. Staff at
CTLD are well aware of risk factors that are associated with irregular adherence and poor
treatment outcomes. In their care practices, they display sensitivity and understanding of ‘the
social’ in patients who present with multiple, overlapping risk factors [25]. In theory, respond-
ing positively to risk factors on the psycho-social risk screening tool used in the intervention
study entitled a patient to three different ‘streams’ of support: social assistance, psychological
support, or specific services of a substance use specialist, a narcologist. In practice, however,
the separation of these issues as distinct encourages a view that they must be tackled separately,
with financial and human resources outside of the purview of TB care, rather than in an inte-
grated manner.
The division between the ‘medical’ and the ‘social’ in TB patients governs how different
staff members communicate with patients at different phases of the patient trajectory. The ini-
tial phase of coming to terms with a serious diagnosis is a crucial point for communication
with patients. However, in this setting, the hospital environment, the emphasis on technical
knowledge about treatment procedures and the principle of isolation, although medically
sound, may reinforce patients’ sense of uncertainty, powerlessness, and dependency. As sug-
gested in the patient and staff interviews, they may not be receptive to information at the point
when they are still coming to terms with the diagnosis. The relief expressed by patients in this
study when they transferred to ambulatory care and experienced what Kaspar referred to as
‘humane care’ underlines the importance of moving towards decentralised, patient-centred
approaches to DR-TB care, as is the case in a growing number of resource-poor settings.
Professional hierarchies and the division of labour between doctors, nurses, and ancillary
staff further hinder an integrated and patient-centred approach to patient care. A limited view
of what ‘social assistance’ is on the one hand, and an overly medicalised view of psychosocial
support on the other, result in the potentially misleading impression that there are not enough
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resources to respond to vulnerable patients. Restrictions on the job description parameters of
potentially key individuals, for example, the social worker and the courier, who both said they
lacked ‘professional knowledge’ about TB, result in missed opportunities for patient-centred
care that takes patients’ life experiences into account. At the same time, the medicalisation of
alcohol and drug use means that the TB staff see these issues as out of their domain and only
manageable within specialist services that are few in number and potentially costly for
patients.
A clinical approach to assessing adherence patterns quantifies individual episodes of poor
adherence as ‘missed doses’. In this paper, we suggest that ‘adherence to treatment’ should be
seen as part of patients’ longer health-seeking trajectories within which individuals’ options
and choices to engage with the health system may be constrained by their position within risk
environments [15]. ‘Risk screening’ tools for poor adherence can be modified to move away
from an emphasis of individual traits to an elucidation of underlying structural issues, as
recently proposed by Bourgois and colleagues [26]. Closer attention to what is communicated
to the patient (and how) at different stages of diagnosis and treatment initiation may support a
more patient-centred approach to knowledge transfer and treatment literacy. Small adjust-
ments can be made within clinic routines and communication practices to support treatment
adherence of vulnerable TB patients through more dialogue and interaction at critical points
along their trajectory of care: these appear to be the moment of diagnosis, transition into
ambulatory care, and the ‘normalisation’ of taking daily treatment. Concurring with Lucenko
and colleagues [1] who emphasise the need for additional attention and support of vulnerable
patients to prevent unsuccessful treatment outcomes, we see the critical importance of inte-
grating medical and social aspects of TB care within the clinic to encourage better treatment
outcomes for vulnerable patients. However, this goes beyond compartmentalising psychiatric,
alcohol, and drug addiction issues separately which may only act to further fragment care and
stigmatise patients.
Recent global TB control strategy statements and action frameworks [7,27] spell out the
need to address underlying social determinants and incorporate social support and protection
as essential components of TB care. More recently a move toward a ‘people-centred’ model of
TB care, defined as care that is “. . .focused on and organized around the health needs and
expectations of people and communities rather than on patients or diseases” [28] has been pro-
moted by the World Health Organization’s Regional Office for Europe [29]. This move repre-
sents an important shift in the paradigm of TB care which, as we suggested at the outset of this
paper, has long been dominated by a top-down and paternalistic view of patients, failing to
adequately take account of the heterogeneity and diverse circumstances of individuals who
contract TB. A European Union consensus statement [30] on TB control in big cities and
urban risk groups specifically recommends integrated support consisting of collaboration to
promote suitable housing for homeless people; providing access to social support for all vul-
nerable populations; and identification of barriers and promotion of access to healthcare ser-
vices [30]. Evidence from older initiatives in European cities London [31] and Barcelona [32],
show that interventions providing social and other support services alongside medical care can
produce good outcomes for TB patients. More recent guidance on what interventions work to
improve early diagnosis of tuberculosis and treatment completion in vulnerable populations
features in systematic reviews of research undertaken in low to medium incidence countries
[33,34]. However, beyond policy statements and promising research, operationalising inte-
grated and patient-centred care as routine practice within strongly centralised and medicalised
systems of TB control is challenging. In order for the Latvian health system to become more
responsive to the complex realities of non-conforming patients, standardised programmatic
approaches for TB control must be balanced against flexibility and innovation in the
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organisation and delivery of care. Joint action on integrating social and medical care is
urgently needed, as has been proposed in other settings like the UK [35]. At the time of our
submission, approval of Lativan government legislation in towards this goal was scheduled for
the end of 2018 –if enacted, this may gradually bring about the required change in the way the
package of TB care for vulnerable individuals in Latvia is defined and provided.
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